About: Invex Therapeutics Ltd, a biopharmaceutical company, engages in the research and development of efficacious treatments for neurological conditions in Australia. It is involved in developing Exenatide, a treatment for neurological conditions derived from or involving raised intracranial pressure, such as idiopathic intracranial hypertension, acute stroke, and traumatic brain injury that has completed Phase III clinical trial. The company has a collaboration with Tessara Therapeutics. Invex Therapeutics Ltd was incorporated in 2019 and is based in Perth, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.09 (-5.56%)
IXC ASX INVEX Therapeutics Ltd
INVEX Therapeutics Ltd share price
Atividade de preço de IXC
Último preço
$ 0,090
Variação (24h)
-0,01 AUD (5,56%)
Volume
4.22K
Volume (média 4 sem.)
-
Abertura
$ 0,09
Variação do dia
$ 0,09 - $ 0,09
Fechamento anterior
$ 0,09
Último negócio
11 Nov, 3:47 am GMT+0
Atrasado
11 Nov, 3:47 am GMT+0
IXC price performance
Atrasado
11 Nov, 3:47 am GMT+0
IXC details
quote.marketSignals